The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArc Minerals Regulatory News (ARCM)

Share Price Information for Arc Minerals (ARCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.775
Bid: 1.75
Ask: 1.80
Change: 0.055 (3.19%)
Spread: 0.05 (2.857%)
Open: 1.725
High: 1.78
Low: 1.78
Prev. Close: 1.725
ARCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with Anglo American & Investor Webinar

12 May 2022 07:00

RNS Number : 1741L
Arc Minerals Limited
12 May 2022
 

12 May 2022

Arc Minerals Ltd

('Arc Minerals' or the 'Company')

Agreement with Anglo American & Investor Webinar

Arc Minerals is pleased to announce that it has entered into an agreement with a subsidiary of Anglo American plc, ("Anglo American") (the "Agreement"). Under the Agreement the parties intend to form a joint venture with respect to the Company's Copper-Cobalt project located in the North-Western province of Zambia ("Joint Venture") and Anglo American will have the right to retain a 70% ownership in the Joint Venture for an aggregate investment by Anglo American of up to USD 88,500,000, including cash consideration of up to USD 14,500,000.

Nick von Schirnding, Executive Chairman of Arc Minerals, commented:

"This agreement represents a major turning point for Arc and follows many months of negotiations. I am delighted to be signing this agreement with Anglo American which will, upon execution and completion of the definitive agreements, result in the potential for significant investment by a reputable major mining company in the tenements in north west Zambia and a very exciting time ahead for us."

The key commercial terms of the Joint Venture that have been agreed in principle in the Agreement are as follows:

- Upon signing of the Joint Venture Documents ("Effective Date"), a Joint Venture vehicle will be formed with initial ownership interests by Anglo American and Arc of 70% and 30%, respectively ("Initial Ownership Interests");

 

- Anglo American has the right to retain an Ownership Interest of 51%, by:

funding exploration expenditures equal to USD 24,000,000 on or before the date that is 180 days after the third anniversary of the Effective Date ("Phase I End Date"); and

making cash payments to Arc Minerals totalling up to USD 14,500,000, as follows:

§ USD 3,500,000 upon signing of the Joint Venture Documents ("Effective Date");

§ USD 1,000,000 on the first anniversary of the Effective Date;

§ USD 1,000,000 on the second anniversary of the Effective Date;

§ USD 1,000,000 on the third anniversary of the Effective Date; and

§ USD 8,000,000 by the Phase I End Date.

 

- Following the completion of Phase I, Anglo American will have the right to retain an additional ownership interest equal to 9% (for a total ownership interest of 60%) by funding USD 20,000,000 of additional exploration expenditures within 2 years of the Phase I End Date ("Phase II End Date")

 

- Following the completion of Phase II, Anglo American will have the right to retain an additional ownership interest equal to 10% (for a total ownership interest of 70%) by funding USD 30,000,000 within 2 years of the Phase II End Date.

 

- Anglo American, for as long as it holds the largest interest in the Joint Venture, shall have the right to nominate three directors and Arc shall have the right to nominate two directors. Joint Venture board decisions shall be adopted by simple majority vote.

The Agreement sets out the core principles under which the Joint Venture will be formed subject to satisfactory due diligence, a restructuring of the Company's assets in preparation for the Joint Venture, negotiation and execution of definitive agreements, the approval of the transaction by the relevant boards of directors and the relevant government and regulatory authorities and other customary conditions.

An exclusivity period has been agreed for up to 90 days to allow for due diligence, and up to an additional 90 days for the negotiation and execution of the Joint Venture Documents.

Investor Webinar

Arc will be hosting an Investor Webinar at 11am on Thursday 12 May 2022.

 

Participants are invited to pre-register for the conference using the link below. Please note that registration is a pre-requisite to access the conference:

https://us02web.zoom.us/webinar/register/WN_UwxTACk4S4mJYJlZ-I-PIA

The Company also invites shareholders to submit questions in advance via email to info@arcminerals.com 

Please note that until the Q&A session has begun that all participants will initially be muted without audio or video stream with the exception of Company management.

Market Abuse Regulation (MAR) Disclosure

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

**ENDS**

Contacts

Arc Minerals Ltd

Nick von Schirnding (Executive Chairman)

 

+44 (0) 20 7917 2942

 

Rothschild & Co (Financial Adviser)

Roger Ewart Smith / Muhammad Jaffer

 

+44 20 7280 5000

 

SP Angel (Nominated Adviser & Joint Broker)

Ewan Leggat / Adam Cowl

 

+44 (0) 20 3470 0470

 

WH Ireland Limited (Joint Broker)

Harry Ansell / Katy Mitchell

 

+44 (0) 20 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRGPUAPAUPPGQG
Date   Source Headline
2nd Mar 20212:57 pmRNSOption Exercise
23rd Feb 20217:00 amRNSChange of Accounting Reference Date
11th Feb 20213:59 pmRNSOption Exercise
10th Feb 20217:00 amRNSInvestor Conference Call
21st Jan 20217:00 amRNSHolding(s) in Company
20th Jan 202111:55 amRNSInterim Results
14th Jan 20212:06 pmRNSSecond Price Monitoring Extn
14th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 20219:05 amRNSSecond Price Monitoring Extn
13th Jan 20219:00 amRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSUpdate on Exclusivity Agreement
12th Jan 20217:00 amRNSPlacing with UK Institution
23rd Dec 20205:03 pmRNSConvertible Loan Note Facility Extension
15th Dec 20204:32 pmRNSGrant of Options
15th Dec 20204:27 pmRNSDelay in Publication of Interim Results
15th Dec 20203:08 pmRNSFirst Phase of Proof of Concept Study Completed
9th Dec 20204:30 pmRNSFurther Drill Results from Fwiji and Muswema
9th Dec 20204:05 pmRNSFurther drill results from Fwiki and Muswema
7th Dec 202011:20 amRNSAnglo American Update
4th Dec 20202:06 pmRNSSecond Price Monitoring Extn
4th Dec 20202:00 pmRNSPrice Monitoring Extension
26th Nov 20205:09 pmRNSResignation of Non-executive Director
24th Nov 20202:05 pmRNSSecond Price Monitoring Extn
24th Nov 20202:00 pmRNSPrice Monitoring Extension
24th Nov 202011:05 amRNSSecond Price Monitoring Extn
24th Nov 202011:00 amRNSPrice Monitoring Extension
24th Nov 20209:05 amRNSSecond Price Monitoring Extn
24th Nov 20209:00 amRNSPrice Monitoring Extension
5th Nov 20205:30 pmRNSResult of Annual General Meeting
30th Oct 20207:00 amRNSDrill Results Confirm Fwiji as a Major Target
29th Oct 20207:00 amRNSBoard Appointment
12th Oct 20204:34 pmRNS2020 Annual Report and Notice of AGM
30th Sep 202011:27 amRNSDelay in Publication of 2020 Annual Report
21st Sep 20206:05 pmRNSBlock Admission Application
21st Sep 20207:00 amRNSDrilling and Assay update
9th Sep 20205:21 pmRNSWarrant Exercise
24th Aug 20208:34 amRNSBoard Change
14th Aug 20202:09 pmRNSWarrant Exercise
11th Aug 202011:44 amRNSSale of Sturec Update
6th Aug 20202:46 pmRNSWarrant Exercise
4th Aug 20207:00 amRNSWarrant Exercise
3rd Aug 20202:00 pmRNSPrice Monitoring Extension
3rd Aug 202011:00 amRNSPrice Monitoring Extension
22nd Jul 20201:10 pmRNSInvestor Conference Call
14th Jul 20204:41 pmRNSSecond Price Monitoring Extn
14th Jul 20204:36 pmRNSPrice Monitoring Extension
14th Jul 20201:29 pmRNSDirectors' Dealing
14th Jul 20209:51 amRNSExclusivity Agreement with Anglo American
29th Jun 20207:00 amRNSDRILLING COMMENCES
5th Jun 20203:38 pmRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.